Literature DB >> 9689155

End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compar ed to other causes of ESRD.

E P Cohen1, W F Piering, C Kabler-Babbitt, J E Moulder.   

Abstract

Chronic renal failure after successful bone marrow transplantation (BMT) may diminish the quality of life and may also evolve to end-stage renal disease (ESRD) requiring chronic dialysis. Individual reports suggest poor survival of such patients. We evaluated the survival with ESRD after BMT by the case-control method. We found that patients who develop ESRD after BMT have a significantly decreased survival as compared with non-BMT patients. This was true for both diabetic and nondiabetic ESRD (both p < 0.03). These data demonstrate the poor outcome of ESRD after BMT which emphasizes the need for a better understanding of chronic renal failure after BMT.

Entities:  

Mesh：

Year:  1998        PMID： 9689155     DOI： 10.1159/000045085

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


  13 in total

1.  National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

Authors:  Michael L Nieder; George B McDonald; Aiko Kida; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Michael A Pulsipher; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-01       Impact factor: 5.742

Review 2.  Chronic kidney disease after hematopoietic stem cell transplantation.

Authors:  Eric P Cohen; Priya Pais; John E Moulder
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

Review 3.  Renal function following hematological stem cell transplantation in childhood.

Authors:  Ludwig Patzer; Karim Kentouche; Felix Ringelmann; Joachim Misselwitz
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

Review 4.  Chronic kidney disease after hematopoietic cell transplantation: a systematic review.

Authors:  M J Ellis; C R Parikh; J K Inrig; M Kanbay; M Kambay; U D Patel
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

5.  Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.

Authors:  Eric P Cohen; Amy A Irving; William R Drobyski; John P Klein; Jakob Passweg; Julie-An M Talano; Mark B Juckett; John E Moulder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

6.  Bone marrow transplant nephropathy successfully treated with angiotensin-converting enzyme inhibitor.

Authors:  Shizunori Ichida; Keiko Okada; Michie Itoh; Rieko Okada; Noritoshi Katoh; Masanobu Kasai; Yukio Yuzawa
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

7.  High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model.

Authors:  Fritz Sieber; Sarah A Muir; Eric P Cohen; Paula E North; Brian L Fish; Amy A Irving; Marylou Mäder; John E Moulder
Journal:  Radiat Res       Date:  2009-03       Impact factor: 2.841

Review 8.  Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children.

Authors:  Kiran Upadhyay; Richard N Fine
Journal:  Pediatr Nephrol       Date:  2013-08-16       Impact factor: 3.714

9.  Noninvasive assessment of radiation-induced renal injury in mice.

Authors:  Anis Ahmad; Junwei Shi; Saba Ansari; Jumana Afaghani; Judith Molina; Alan Pollack; Sandra Merscher; Youssef H Zeidan; Alessia Fornoni; Brian Marples
Journal:  Int J Radiat Biol       Date:  2021-03-15       Impact factor: 2.694

Review 10.  Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.

Authors:  Sangeeta Hingorani
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.